# Colinz Laboratories Ltd (COLINZ)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹42.01
Day Change: -0.99%
52W High: ₹87.91
52W Low: ₹36.11
Market Cap: ₹11 Cr

## Valuation
P/E: 22.98
P/B: 1.13
EPS: ₹1.96
Book Value: ₹39.89
Dividend Yield: 0%

## Returns
1Y Return: -25.38%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Colinz Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Colinz Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Quarterly Report: Financial Results For The Quarter And Year Ended On 31-03-2026
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-20T08:45:20.390Z
Price History Updated: 2026-05-25T05:42:06.599Z
Latest Price History Date: 2026-05-20
Technicals Updated: 2026-05-25T05:42:06.599Z
Quant Updated: 2026-05-25T05:42:06.599Z
Sentiment Updated: 2026-05-25T05:42:06.599Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹7 Cr
Operating Profit: ₹0 Cr (OPM 5.52%)
Net Profit: ₹0 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2022: Rev ₹7Cr | PAT ₹0Cr | OPM 5.52%
FY 2023: Rev ₹7Cr | PAT ₹0Cr | OPM 7.04%
FY 2024: Rev ₹7Cr | PAT ₹0Cr | OPM 5.87%

## Balance Sheet (FY 2022)
Total Assets: ₹10 Cr
Total Liabilities: ₹2 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/colinz
Disclaimer: For research and education only. Not investment advice.